Meeder Asset Management Inc Wave Life Sciences Ltd. Transaction History

Meeder Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.14 - $5.15 $816 - $1,339	-260 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$4.89 - $7.12 $9,423 - $13,720	-1,927 Reduced 88.11%	260 $0
Q2 2021 Aug 09, 2021	SELL	$5.65 - $7.47 $7,994 - $10,570	-1,415 Reduced 39.28%	2,187 $15,000
Q1 2021 Apr 28, 2021	BUY	$5.61 - $12.01 $20,207 - $43,260	3,602 New	3,602 $20,000
Q4 2020 Feb 09, 2021	SELL	$6.99 - $9.26 $4,194 - $5,556	-600 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$8.49 - $19.54 $1,349 - $3,106	159 Added 36.05%	600 $5,000
Q2 2020 Aug 11, 2020	SELL	$7.44 - $11.29 $7,618 - $11,560	-1,024 Reduced 69.9%	441 $4,000
Q1 2020 May 15, 2020	BUY	$6.94 - $14.22 $10,167 - $20,832	1,465 New	1,465 $14,000
Q2 2019 Aug 05, 2019	SELL	$22.93 - $42.84 $6,901 - $12,894	-301 Closed	0 $0
Q1 2019 Apr 16, 2019	SELL	$32.69 - $47.91 $1,372 - $2,012	-42 Reduced 12.24%	301 $12,000
Q4 2018 Jan 17, 2019	BUY	$37.1 - $50.11 $12,725 - $17,187	343 New	343 $15,000
Q2 2018 Jul 24, 2018	SELL	$33.85 - $50.65 $981 - $1,468	-29 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$32.45 - $54.7 $876 - $1,476	27 Added 1350.0%	29 $1,000
Q4 2017 Feb 02, 2018	BUY	$21.8 - $39.35 $43 - $78	2	2 $0

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.24B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.